Voretigene Neparvovec – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Tue, 25 Jan 2022 12:52:40 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Voretigene Neparvovec – VJRegenMed https://mirror.vjregenmed.com 32 32 The future of gene therapies for the eye https://mirror.vjregenmed.com/video/hie07cgghs4-the-future-of-gene-therapies-for-the-eye/ Tue, 23 Nov 2021 15:28:47 +0000 http://13.40.107.223/video/hie07cgghs4-the-future-of-gene-therapies-for-the-eye/ Sue Washer, Applied Genetic Technologies Corporation, Alachua, FL, discusses future advancements within the field of ophthalmology gene therapies. With the advent of voretigene neparvovec, the first approved gene therapy for retinal diseases, the future of gene therapies treating vision loss is promising. Adeno-associated viruses (AAVs) additionally have potential uses other than as a vector, including delivering RNA and CRISPR-Cas 9 therapies. This interview took place at Meeting on the Mesa 2021.

]]>